Gengyve Mouthwash: A Revolutionary Oral Care Solution

Gengyve mouthwash, produced by Incline Village Global Farma (IVGF), represents a major innovation in oral care. This FDA-registered OTC product combines cutting-edge research with natural ingredients to create an effective, safe, and sustainable oral care solution.

Developed in collaboration with leading dental institutions, Gengyve offers comprehensive oral health benefits backed by scientific research and rigorous safety evaluations.

Learn More

Key Features & Benefits

Scientific Foundation

Developed in collaboration with researchers at the University of California, San Francisco (UCSF) and the University of Milano, Gengyve's formulation includes ingredients specifically studied for their ability to maintain oral hygiene and prevent common oral health issues. This collaboration ensured the product's formulation is backed by sound scientific principles.To view the peer-reviewed publication click here.

FDA-Registered OTC Product

Gengyve is listed under NDC 82161-141 as an FDA approved OTC product, OTC243264R. This registration signifies that the product has passed necessary safety, efficacy, and manufacturing standards.

Virucidal Efficacy

Tested under the European Standard UNI EN14476+A2:2019, Gengyve demonstrated significant virucidal efficacy against Vaccinia Virus, making it a potent product in combating not just common oral bacteria but also more resistant pathogens. There is a battery of pre-market testing available to view here.

Natural & Safe

Gengyve is formulated with ingredients such as hyaluronic acid, cetylpyridinium chloride (CPC), castor oil and other natural ingredients. This unique combination promotes hydration, supports mucous membrane regeneration, and offers protection against dental plaque and gum disease.

Incline Village Global Farma
(IVGF) and Regulatory Compliance

Incline Village Global Farma, the manufacturer of Gengyve, is a Nevada-based company committed to producing
advanced healthcare products that are both scientifically sound and accessible to the general public. The company has achieved full FDA compliance and is recognized by Dun & Bradstreet (DUNS Number: 117758236), giving it credibility within the healthcare and pharmaceutical sectors.

  • FDA Registration: IVGF is registered with the FDA under Labeler Code 82161, which allows it to produce and market OTC drugs, ensuring Gengyve adheres to the highest safety and quality standards.
  • DUNS Registration: The company is also listed under DUNS Number 117758236, which establishes its legitimacy and transparency as a pharmaceutical manufacturer.

Product Testing & FDA Registration

Safety Evaluations

Gengyve mouthwash has undergone rigorous safety evaluations and meets both U.S. FDA and European regulatory standards. It has been granted OTC status under designation OTC243264R, and its Material Safety Data Sheet (MSDS) This document confirms that it is non-toxic and safe for consumer use. The ingredients have been individually assessed and proven to be safe when used in recommended concentrations.

Independently Tested

In independent testing conducted in collaboration with CDR Pharma and Prochemia laboratories, Gengyve demonstratedits ability to kill viruses and bacteria effectively, including its virucidal activity against Vaccinia Virus. This adds anadditional layer of protection for users, making Gengyve not only a preventative oral care product but also a protectiveone against a wide range of pathogens.

Full OTC Registered

As a fully registered OTC product under NDC 82161-141, Gengyve can be marketed and distributed without a prescription, ensuring broader accessibility for consumers. This classification underscores its safety, efficacy, and compliance with federal regulations.

Industry News & Insights

  • Gengyve for Institutional Use Beyond the Dental Clinic

    Gengyve for Institutional Use Beyond the Dental...

    Improved oral hygiene protocols show substantial benefits to other hospital outcome measures. Lower post-surgical infection rates, lower complications in ICU management, less risk of complications from radiation, chemotherapy or immunosuppression...

    Gengyve for Institutional Use Beyond the Dental...

    Improved oral hygiene protocols show substantial benefits to other hospital outcome measures. Lower post-surgical infection rates, lower complications in ICU management, less risk of complications from radiation, chemotherapy or immunosuppression...

1 3

Further Information & Registrations

  • Address

    930 Tahoe Blvd,
    Ste. 802-610
    Incline Village, NV
    89451-9451

  • Phone Number

    + 1 415 385 0665

  • Email Address

    info@gengyveusa.com

  • Registrations

    FDA Labeler Code: 82161
    DUNS Number: 117758236
    NDC: 82161-141
    OTC243264R